On 2024-03-20, Vera Therapeutics, Inc. (VERA) announced earnings per share of $-0.58 for the fiscal quarter ending 2023-12-31, missing the average analyst estimate of $-0.53.
The next expected annoucement date for quarterly earnings is 2024-05-09, with an average estimated earnings per share of $-0.53 for the fiscal quarter ending 2024-03-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2024-03-20 | 2023-12-31 | $-0.53 | $-0.58 |
| 2023-11-09 | 2023-09-30 | $-0.50 | $-0.45 |
| 2023-08-10 | 2023-06-30 | $-0.69 | $-0.46 |
| 2023-05-11 | 2023-03-31 | $-0.59 | $-0.80 |
| 2023-03-28 | 2022-12-31 | $-0.93 | $-1.19 |
| 2022-11-09 | 2022-09-30 | $-0.72 | $-0.91 |
| 2022-08-10 | 2022-06-30 | $-0.72 | $-0.55 |
| 2022-05-16 | 2022-03-31 | $-0.67 | $-0.71 |
| 2022-03-24 | 2021-12-31 | $-0.49 | $-0.79 |
| 2021-11-10 | 2021-09-30 | $-0.60 | $-0.36 |
| 2021-08-16 | 2021-06-30 | $-0.39 | $-0.33 |
| 2021-06-24 | 2021-03-31 | $-1.95 | $-12.23 |